Techniques in Regional Anesthesia & Pain Management
Volume 9, Issue 4 , Pages 204-211 , October 2005

Substance use disorders in patients with chronic pain: The role of temperament in successful treatment

  • Andrew F. Angelino, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests and correspondence: Dr. Andrew F. Angelino, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 4940 Eastern Avenue, A4C-461A, Baltimore, MD 21224
    • ,
  • Michael R. Clark, MD, MPH
    • ,
  • Glenn J. Treisman, MD, PhD

References 

  1. Meldrum ML . A capsule history of pain management . JAMA . 2003;290:2470–2475
  2. In:  Turk DC ,  Meichenbaum D ,  Genest M editor. Pain and Behavioral Medicine (A Cognitive-Behavioral Perspective) . New York, NY: Guilford Press; 1983;
  3. Merskey H , Lindblom U , Mumford JM , et al.   Pain terms (a current list with definitions and notes on usage) . Pain Suppl . 1986;3:S215–S221
  4. Bennett GJ . Update on the neurophysiology of pain transmission and modulation (focus on the NMDA-receptor) . J Pain Sympt Manage . 2000;19(suppl 1):S2–S6
  5. Besson JM . The neurobiology of pain . Lancet . 1999;353:1610–1615
  6. Bolay H , Moskowitz MA . Mechanisms of pain modulation in chronic syndromes . Neurology . 2002;59(suppl 2):S2–S7
  7. In:  Borsook D editors. Molecular Neurobiology of Pain, Progress in Pain Research and Management (vol 9) . Seattle, WA: IASP Press; 1997;
  8. Cesaro P , Ollat H . Pain and its treatments . Eur Neurol . 1997;38:209–215
  9. Dickenson AH , Matthews EA , Suzuki R . Neurobiology of neuropathic pain (mode of action of anticonvulsants) . Eur J Pain . 2002;6(suppl A):51–60
  10. Hunt SP , Mantyh PW . The molecular dynamics of pain control . Nat Rev Neurosci . 2001;2:83–91
  11. Price DD . Psychological and neural mechanisms of the affective dimension of pain . Science . 2000;288:1769–1772
  12. Riedel W , Neeck G . Nociception, pain, and antinociception (current concepts) . Z Rheumatol . 2001;60:404–415
  13. In:  Wall PD ,  Melzack R editor. Textbook of Pain . ed 3. Edinburgh: Churchill Livingstone; 1994;
  14. Zimmermann M . Pathobiology of neuropathic pain . Eur J Pharmacol . 2001;429:23–37
  15. Cleeland CS . Measurement of pain by subjective report . In:  Chapman CR ,  Loeser JD editor. Issues in Pain Measurement (Advances in Pain Research and Therapy) . New York, NY: Raven Press Ltd; 1989;p. 391–403
  16. Wilson KG , Mikail SF , D’Eon JL , et al.   Alternative diagnostic criteria for major depressive disorder in patients with chronic pain . Pain . 2001;91:227–234
  17. Clark MR , Cox TS . Refractory chronic pain . Psychiatr Clin North Am . 2002;25:71–88
  18. Fishbain DA . Approaches to treatment decisions for psychiatric comorbidity in the management of the chronic pain patient . Med Clin North Am . 1999;83:737–760
  19. American Psychiatric Association . In: Diagnostic and Statistical Manual of Mental Disorders . ed 4. Washington DC: American Psychiatric Press Inc; 1994;
  20. Alcoff J , Jones E , Rust P , Newman R . Controlled trial of imipramine for chronic low back pain . J Fam Pract . 1982;14:841–846
  21. Currie SR , Hodgins DC , Crabtree A , et al.   Outcome from integrated pain management treatment for recovering substance abusers . J Pain . 2003;4:91–100
  22. Peles E , Schreiber S , Gordon J , et al.   Significantly higher methadone dose for methadone maintenance treatment (MMT) patients with chronic pain . Pain . 2005;113:340–346
  23. Stack K , Cortina J , Samples C , et al.   Race, age, and back pain as factors in completion of residential substance abuse treatment by veterans . Psychiatr Serv . 2000;51:1157–1161
  24. Trafton JA , Oliva EM , Horst DA , et al.   Treatment needs associated with pain in substance use disorder patients (implications for concurrent treatment) . Drug Alcohol Depend . 2004;73:23–31
  25. Michna E , Ross EL , Hynes WL , et al.   Predicting aberrant drug behavior in patients treated for chronic pain (importance of abuse history) . J Pain Sympt Manage . 2004;28:250–258
  26. Dersh J , Polatin PB , Gatchel RJ . Chronic pain and psychopathology (research findings and theoretical considerations) . Psychosom Med . 2002;64:773–786
  27. Weaver M , Schnoll S . Abuse liability in opioid therapy for pain treatment in patients with an addiction history . Clin J Pain . 2002;18:S61–S69
  28. Reid MC , Engles-Horton LL , Weber MB , et al.   Use of opioid medications for chronic noncancer pain syndromes in primary care . J Gen Intern Med . 2002;17:238–240
  29. Kouyanou K , Pither CE , Wessely S . Medication misuse, abuse and dependence in chronic pain patients . J Psychosom Res . 1997;43:497–504
  30. Hoffman NG , Olofsson O , Salen B , et al.   Prevalence of abuse and dependency in chronic pain patients . Int J Addict . 1995;30:919–927
  31. Fishbain DA , Rosomoff HL , Rosomoff RS . Drug abuse, dependence (addiction in chronic pain patients) . Clin J Pain . 1992;8:77–85
  32. Nicholson B . Responsible prescribing of opioids for the management of chronic pain . Drugs . 2003;63:17–32
  33. Eysenck HJ , Rachman S . The Causes and Cures of Neurosis . San Diego, CA: Robert R. Knapp; 1965; pp 14-28
  34. In:  Costa PT ,  Widiger TA editor. Personality Disorders and the Five-Factor Model of Personality . Washington DC: American Psychological Association; 1994;
  35. Vendrig AA , Derksen JJ , de Mey HR . MMPI-2 Personality Psychopathology Five (PSY-5) and prediction of treatment outcome for patients with chronic back pain . J Pers Assess . 2000;74:423–438
  36. Weisberg JN . Personality and personality disorders in chronic pain . Curr Rev Pain . 2000;4:60–70
  37. Weisberg JN , Vaillancourt PD . Personality factors and disorders in chronic pain . Semin Clin Neuropsychiatr . 1999;4:155–166
  38. Riley JL , Robinson ME . Validity of MMPI-2 profiles in chronic back pain patients (differences in path models of coping and somatization) . Clin J Pain . 1998;14:324–335
  39. Vendrig AA . The Minnesota Multiphasic Personality Inventory and chronic pain (a conceptual analysis of a long-standing but complicated relationship) . Clin Psychol Rev . 2000;20:533–559
  40. Yardley L , Luxon L . Treating dizziness with vestibular rehabilitation . Br Med J . 1994;308:1252–1253
  41. Brown RL , Patterson JJ , Rounds LA , et al.   Substance use among patients with chronic pain . J Fam Pract . 1996;43:152–160
  42. Savage SR . Addiction in the treatment of pain (significance, recognition and management) . J Pain Sympt Manage . 1993;8:265–278
  43. Miotto K , Compton P , Ling W , et al.   Diagnosing addictive disease in chronic pain patients . Psychosomatics . 1996;37:223–235
  44. Fishbain D , Cutler R , Rosomoff H . Comorbid psychiatric disorders in chronic pain patients . Pain Clin . 1998;11:79–87
  45. Aronoff GM . Opioids in chronic pain management (is there a significant risk of addiction?) . Curr Rev Pain . 2000;4:112–121
  46. Polatin PB , Kinney RK , Gatchel RJ , et al.   Psychiatric illness and chronic low back pain . Spine . 1993;18:66–71
  47. Fordyce W , Fowler R , Lehmann J , et al.   Operant conditioning in the treatment of chronic pain . Arch Phys Med Rehab . 1973;54:399–408
  48. Chapman SL , Byas-Smith MG , Reed BA . Effects of intermediate- and long-term use of opioids on cognition in patients with chronic pain . Clin J Pain . 2002;18:S83–S90
  49. Hendler N , Cimini C , Ma T , et al.   A comparison of cognitive impairment due to benzodiazepines and to narcotics . Am J Psychiatry . 1980;137:828–830
  50. Lomardo WK , Lambardo B , Goldstein A . Cognitive functioning under moderate and low dosage methadone maintenance . Int J Addict . 1976;11:389–401
  51. McNairy SI , Maruta T , Ivnik RJ , et al.   Prescription medication dependence and neuropsychological function . Pain . 1984;18:169–177
  52. Sabatowski R , Schwalen S , Rettig K , et al.   Driving ability under long-term treatment with transdermal fentanyl . J Pain Sympt Manage . 2003;25:38–47
  53. Zielger DK . Opiate and opioid use in patients with refractory headache . Cephalalgia . 1994;14:5–10
  54. Gilson AM , Joranson DE . Controlled substances and pain management (changes in knowledge and attitudes of state medical regulators) . J Pain Sympt Manage . 2001;21:227–237
  55. Rosenblum A , Joseph H , Fong C , et al.   Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities . JAMA . 2003;289:2370–2378
  56. Jamison RN , Kauffman J , Katz NP . Characteristics of methadone maintenance patients with chronic pain . J Pain Sympt Manage . 2000;19:53–62
  57. Hasenbring M , Marienfeld G , Kuhlendahl D , et al.   Risk factors of chronicity in lumbar disc patients. A prospective investigation of biologic, psychologic, and social predictors of therapy outcome . Spine . 1994;19:2759–2765
  58. Haythornthwaite JA , Sieber WJ , Kerns RD . Depression and the chronic pain experience . Pain . 1991;46:177–184
  59. Kerns RD , Haythornthwaite JA . Depression among chronic pain patients (cognitive-behavioral analysis and effect on rehabilitation outcome) . J Consult Clin Psychol . 1988;56:870–876
  60. Magni G , Schifano F , DeLeo D . Pain as a symptom in elderly depressed patients. Relationship to diagnostic subgroups . Eur Arch Psychiatry Neurol Sci . 1985;235:143–145
  61. Magni G , Marchetti M , Moreschi C , et al.   Chronic musculoskeletal pain and depressive symptoms in the National Health and Nutrition Examination. I. Epidemiologic follow-up study . Pain . 1993;53:163–168
  62. Weickgenant AL , Slater MA , Patterson TL , et al.   Coping activities in chronic low back pain (relationship with depression) . Pain . 1993;53:95–103
  63. Mantyselka P , Ahonen R , Viinamaki H , et al.   Drug use by patients visiting primary care physicians due to nonacute musculoskeletal pain . Eur J Pharm Sci . 2002;17:210–216
  64. Druss BG , Rosenheck RA , Sledge WH . Health and disability costs of depressive illness in a major U.S. corporation . Am J Psychiatry . 2000;157:1274–1278
  65. Riley JL , Robinson ME , Wise EA , et al.   Predicting treatment compliance following facial pain evaluation . Cranio . 1999;17:9–16
  66. Fishbain DA . The association of chronic pain and suicide . Semin Clin Neuropsychiatry . 1999;4:221–227
  67. Fishbain DA , Goldberg M , Rosomoff RS , et al.   Completed suicide in chronic pain . Clin J Pain . 1991;7:29–36
  68. Magni G , Rigatti-Luchini S , Fracca F , et al.   Suicidality in chronic abdominal pain (an analysis of the Hispanic Health and Nutrition Examination Survey (HHANES)) . Pain . 1998;76:137–144
  69. Stenager EN , Stenager E , Jensen K . Attempted suicide, depression and physical diseases (a one-year follow-up study) . Psychother Psychosom . 1994;61:65–73
  70. Emanuel EJ , Fairclough DL , Daniels ER , et al.   Euthanasia and physician-assisted suicide (attitudes and experiences of oncology patients, oncologists, and the public) . Lancet . 1996;347:1805–1810
  71. McCracken LM , Turk DC . Behavioral and cognitive-behavioral treatment for chronic pain (outcome, predictors of outcome, and treatment process) . Spine . 2002;27:2564–2573
  72. McCracken LM . Learning to live with the pain (acceptance of pain predicts adjustment in persons with chronic pain) . Pain . 1998;74:21–27
  73. Arnstein P . The mediation of disability by self-efficacy in different samples of chronic pain patients . Disabil Rehabil . 2000;22:794–801
  74. Arnstein P , Caudill M , Mandle CL , et al.   Self-efficacy as a mediator of the relationship between pain intensity, disability and depression in chronic pain patients . Pain . 1999;80:483–491
  75. Turner JA , Jensen MP , Romano JM . Do beliefs, coping, and catastrophizing independently predict functioning in patients with chronic pain? . Pain . 2000;85:115–125

PII: S1084-208X(05)00084-4

doi: 10.1053/j.trap.2005.10.005

Techniques in Regional Anesthesia & Pain Management
Volume 9, Issue 4 , Pages 204-211 , October 2005

Article Tools